IPRIPR2025-00799Terminated-Settled
Intas Pharmaceuticals, Ltd. et al.v.Atossa Therapeutics, Inc.
IPR challenge of US 11261151.
Type
IPR
Filed
Apr 3, 2025
Instituted
Nov 3, 2025
Decided
May 11, 2026
Patent
Application
16641985
Inventor
Steven C. Quay et al
Granted
Mar 1, 2022
01
Timeline
3 milestones
2025-04-03Petition filed
2025-11-03Institution
2026-05-11Terminated
02
Parties & counsel
Petitioner
Intas Pharmaceuticals, Ltd. et al.
Counsel
Menchaca, Alejandroet al
Patent Owner
Atossa Therapeutics, Inc.
Counsel
Raymond, Meganet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →